Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Hepatic Encephalopathy Pilot Study
NCT02255617Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Jul 2014
- Primary completion
- Jul 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in hepatic encephalopathy (HE), sponsored by University of Alberta. Started Jul 2014; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT02255617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255617.